了解乳腺癌-漫长而曲折的道路

Kiven Erique Lukong
{"title":"了解乳腺癌-漫长而曲折的道路","authors":"Kiven Erique Lukong","doi":"10.1016/j.bbacli.2017.01.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Despite a remarkable increase in the depth of our understanding and management of breast cancer in the past 50<!--> <!-->years, the disease is still a major public health problem worldwide and poses significant challenges. The palpability of breast tumors has facilitated diagnosis and documentation since ancient times. The earliest descriptions of breast cancer date back to around 3500<!--> <!-->BCE. For centuries to follow, theories by Hippocrates (460<!--> <!-->BCE) and Galen (200<!--> <!-->CE), attributing the cause of breast cancer to an “excess of black bile” and treatment options including the use of opium and castor oil, prevailed. Surgical resection was introduced in the 18th century. The advent of modern medicine led to the development of novel treatment options that include hormonal, targeted and chemo-therapies. There are still several therapeutic challenges including the treatment of triple negative breast cancer (TNBC), and overcoming drug resistance.</p></div><div><h3>Scope of review</h3><p>The increased incidence and awareness of breast cancer has led to significant changes in diagnosis and treatment in recent decades. But, mankind has come a long way. Herein, I have traced how our understanding of breast cancer has evolved from the early description of the disease around 460<!--> <!-->BCE as “black bile-containing crab-like tumors” to the conventional as a heterogeneous disease with high degree of diversity between and within tumors, as well as among breast cancer patients. How is breast cancer treated today and how do risk factors, breast cancer subtype and drug resistance contribute to the therapeutic challenges at the turn of the 21st century?</p></div><div><h3>Major conclusions</h3><p>Breast cancer remains a serious public health issue worldwide. However, appreciable growth in our understanding of breast cancer in the past century has led to remarkable progress in the early detection, treatment and prevention of the disease. The clinical focus is shifting more towards tailored therapy as more targets are characterized and novel highly innovative approaches are developed.</p></div><div><h3>General significance</h3><p>Tracing the history of breast cancer, highlights how increased awareness of the disease, and progress in research and development have enhance our understanding of the disease.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.01.001","citationCount":"163","resultStr":"{\"title\":\"Understanding breast cancer – The long and winding road\",\"authors\":\"Kiven Erique Lukong\",\"doi\":\"10.1016/j.bbacli.2017.01.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Despite a remarkable increase in the depth of our understanding and management of breast cancer in the past 50<!--> <!-->years, the disease is still a major public health problem worldwide and poses significant challenges. The palpability of breast tumors has facilitated diagnosis and documentation since ancient times. The earliest descriptions of breast cancer date back to around 3500<!--> <!-->BCE. For centuries to follow, theories by Hippocrates (460<!--> <!-->BCE) and Galen (200<!--> <!-->CE), attributing the cause of breast cancer to an “excess of black bile” and treatment options including the use of opium and castor oil, prevailed. Surgical resection was introduced in the 18th century. The advent of modern medicine led to the development of novel treatment options that include hormonal, targeted and chemo-therapies. There are still several therapeutic challenges including the treatment of triple negative breast cancer (TNBC), and overcoming drug resistance.</p></div><div><h3>Scope of review</h3><p>The increased incidence and awareness of breast cancer has led to significant changes in diagnosis and treatment in recent decades. But, mankind has come a long way. Herein, I have traced how our understanding of breast cancer has evolved from the early description of the disease around 460<!--> <!-->BCE as “black bile-containing crab-like tumors” to the conventional as a heterogeneous disease with high degree of diversity between and within tumors, as well as among breast cancer patients. How is breast cancer treated today and how do risk factors, breast cancer subtype and drug resistance contribute to the therapeutic challenges at the turn of the 21st century?</p></div><div><h3>Major conclusions</h3><p>Breast cancer remains a serious public health issue worldwide. However, appreciable growth in our understanding of breast cancer in the past century has led to remarkable progress in the early detection, treatment and prevention of the disease. The clinical focus is shifting more towards tailored therapy as more targets are characterized and novel highly innovative approaches are developed.</p></div><div><h3>General significance</h3><p>Tracing the history of breast cancer, highlights how increased awareness of the disease, and progress in research and development have enhance our understanding of the disease.</p></div>\",\"PeriodicalId\":72344,\"journal\":{\"name\":\"BBA clinical\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.01.001\",\"citationCount\":\"163\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BBA clinical\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S221464741630054X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BBA clinical","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221464741630054X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 163

摘要

尽管在过去的50年里,我们对乳腺癌的理解和管理有了显著的提高,但该疾病仍然是世界范围内的一个主要公共卫生问题,并构成了重大挑战。乳腺肿瘤的可触性自古以来就为诊断和记录提供了便利。关于乳腺癌的最早描述可以追溯到公元前3500年左右。在接下来的几个世纪里,希波克拉底(Hippocrates,公元前460年)和盖伦(Galen,公元200年)的理论将乳腺癌的病因归结为“黑胆汁过多”,治疗方法包括使用鸦片和蓖麻油。手术切除在18世纪被引入。现代医学的出现导致了新的治疗选择的发展,包括激素治疗,靶向治疗和化疗。目前仍存在一些治疗挑战,包括治疗三阴性乳腺癌(TNBC)和克服耐药性。近几十年来,乳腺癌发病率的提高和对乳腺癌认识的提高导致了乳腺癌诊断和治疗的重大变化。但是,人类已经取得了长足的进步。在这里,我追溯了我们对乳腺癌的认识是如何从公元前460年左右的早期描述为“含有黑胆汁的螃蟹样肿瘤”发展到传统的肿瘤之间和肿瘤内部以及乳腺癌患者之间高度多样性的异质性疾病。今天乳腺癌是如何治疗的?风险因素、乳腺癌亚型和耐药性是如何对21世纪初的治疗挑战做出贡献的?主要结论乳腺癌仍然是世界范围内一个严重的公共卫生问题。然而,在过去的一个世纪里,我们对乳腺癌的认识有了明显的增长,导致在早期发现、治疗和预防该疾病方面取得了显著进展。随着更多靶点的特征和新颖的高度创新的方法的开发,临床重点正在更多地转向量身定制的治疗。一般意义追溯乳腺癌的历史,强调如何提高对该疾病的认识,以及研究和开发的进展如何增强了我们对该疾病的了解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Understanding breast cancer – The long and winding road

Background

Despite a remarkable increase in the depth of our understanding and management of breast cancer in the past 50 years, the disease is still a major public health problem worldwide and poses significant challenges. The palpability of breast tumors has facilitated diagnosis and documentation since ancient times. The earliest descriptions of breast cancer date back to around 3500 BCE. For centuries to follow, theories by Hippocrates (460 BCE) and Galen (200 CE), attributing the cause of breast cancer to an “excess of black bile” and treatment options including the use of opium and castor oil, prevailed. Surgical resection was introduced in the 18th century. The advent of modern medicine led to the development of novel treatment options that include hormonal, targeted and chemo-therapies. There are still several therapeutic challenges including the treatment of triple negative breast cancer (TNBC), and overcoming drug resistance.

Scope of review

The increased incidence and awareness of breast cancer has led to significant changes in diagnosis and treatment in recent decades. But, mankind has come a long way. Herein, I have traced how our understanding of breast cancer has evolved from the early description of the disease around 460 BCE as “black bile-containing crab-like tumors” to the conventional as a heterogeneous disease with high degree of diversity between and within tumors, as well as among breast cancer patients. How is breast cancer treated today and how do risk factors, breast cancer subtype and drug resistance contribute to the therapeutic challenges at the turn of the 21st century?

Major conclusions

Breast cancer remains a serious public health issue worldwide. However, appreciable growth in our understanding of breast cancer in the past century has led to remarkable progress in the early detection, treatment and prevention of the disease. The clinical focus is shifting more towards tailored therapy as more targets are characterized and novel highly innovative approaches are developed.

General significance

Tracing the history of breast cancer, highlights how increased awareness of the disease, and progress in research and development have enhance our understanding of the disease.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信